These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37200453)

  • 1. Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent.
    Roy Chowdhury U; Pervan-Steel CL; Sheeler R; Sookdeo HK; Rogers B; Casale R; Dosa PI; Htoo T; Wirostko BM; Fautsch MP
    J Ocul Pharmacol Ther; 2023 Jun; 39(5):332-346. PubMed ID: 37200453
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits.
    Roy Chowdhury U; Kudgus RA; Rinkoski TA; Holman BH; Bahler CK; Hann CR; Reid JM; Dosa PI; Fautsch MP
    PLoS One; 2020; 15(4):e0231841. PubMed ID: 32298376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates.
    Roy Chowdhury U; Kudgus RA; Holman BH; Rinkoski TA; Hann CR; Bahler CK; McCloud E; Appt SE; Reid JM; Dosa PI; Fautsch MP
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):251-260. PubMed ID: 33784195
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug.
    Pervan-Steel CL; Roy Chowdhury U; Sookdeo HK; Casale RA; Dosa PI; Htoo TM; Fautsch MP; Wirostko BM
    Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):26. PubMed ID: 35486069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
    Chung JK; Spencer E; Hunt M; McCauley T; Welty D
    J Ocul Pharmacol Ther; 2018; 34(1-2):224-232. PubMed ID: 29267138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.
    Roy Chowdhury U; Rinkoski TA; Bahler CK; Millar JC; Bertrand JA; Holman BH; Sherwood JM; Overby DR; Stoltz KL; Dosa PI; Fautsch MP
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5731-5742. PubMed ID: 29114841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.
    Acheampong AA; Shackleton M; Tang-Liu DD; Ding S; Stern ME; Decker R
    Curr Eye Res; 1999 Feb; 18(2):91-103. PubMed ID: 10223652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits.
    Iyer GR; Cason MM; Womble SW; Li G; Chastain JE
    J Ocul Pharmacol Ther; 2015 May; 31(4):204-10. PubMed ID: 25775192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
    Weiss SL; Kramer WG
    J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models.
    Prasanna G; Fortner J; Xiang C; Zhang E; Carreiro S; Anderson S; Sartnurak S; Wu G; Gukasyan H; Niesman M; Nair S; Rui E; Lafontaine J; Almaden CD; Wells P; Krauss A
    Exp Eye Res; 2009 Nov; 89(5):608-17. PubMed ID: 19445930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Sirolimus Eye Drops Following Topical Ocular Administration in Rabbits.
    Lin J; Lu Z; Wang Y; Zhang J; Guo J; Huang Y; Lin B; Yang W
    J Ocul Pharmacol Ther; 2023 Dec; 39(10):735-743. PubMed ID: 37579189
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
    Kadam RS; Jadhav G; Ogidigben M; Kompella UB
    Drug Metab Dispos; 2011 Sep; 39(9):1529-37. PubMed ID: 21673129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.
    Proksch JW; Granvil CP; Siou-Mermet R; Comstock TL; Paterno MR; Ward KW
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):335-44. PubMed ID: 19492955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
    Fukano Y; Kawazu K
    Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits.
    Lin J; Sun J; Wang Y; Ma Y; Chen W; Zhang Z; Gui G; Lin B
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):51-6. PubMed ID: 25229266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues.
    Seal JR; Robinson MR; Burke J; Bejanian M; Coote M; Attar M
    J Ocul Pharmacol Ther; 2019; 35(1):50-57. PubMed ID: 30335560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits.
    Arnold JJ; Choksi Y; Chen X; Shimazaki A; Hatten J; Toone EJ; Epstein DL; Challa P
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):179-86. PubMed ID: 19456251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
    Vooturi SK; Kadam RS; Kompella UB
    Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.